<DOC>
	<DOCNO>NCT02466256</DOCNO>
	<brief_summary>This randomize clinical trial compare subjective performance Intraocular lens ( IOL ) implantation , well incision enlargement anterior segment morphology OCT IOL implantation perform microcoaxial phacoemulsification 2.2mm incision use one three injector : Manual screw type ( Monarch III ) , Manual plunger type ( Royale ) motorise injector ( Autosert ) . Further , investigator also look incision integrity compare ingres trypan blue ocular surface anterior chamber .</brief_summary>
	<brief_title>Intra Postoperative Outcomes With 3 Injectors</brief_title>
	<detailed_description>In randomize , clinical trial , three type injector compare : 1 . Manual , screw type injector ( Monarch III ) 2 . Manual , plunger type injector ( Royale , ASICO ) 3 . Motorized injector ( Autosert , Alcon ) Having perform phacoemulsification 2.2mm incision , IOL implantation perform use D cartridge one three injector decide randomized fashion . The investigator evaluate incision enlargement follow point : end phacoemulsification , , end IOL implantation The investigator also look trypan blue ingres anterior chamber ocular surface . At 1 day , 1 week , 1 month surgery anterior segment OCT morphology also study . , surgeon ask subjectively grade ease implantation injector</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Patients undergo phacoemulsification agerelated uncomplicated cataract 2.2mm incision . Nuclear corticonuclear grade 2 4 accord Lens Opacities Classification System ( LOCS III ) Glaucoma , uveitis , shallow anterior chamber ( depth &lt; 2.1mm ) , prior ocular trauma surgery , maximal pupillary dilatation &lt; 6mm , high myopia ( axial length &gt; 25mm ) , posterior polar cataract , dense cataract , IOL power &lt; 19.0 D &gt; 25.0 D</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Intraocular lens implantation</keyword>
</DOC>